On 8 October, the international conference “Personalised Cancer Screening – Lessons Learned and the Way Forward” took place at the University of Latvia in Riga.
Organised as part of the EUCanScreen Joint Action, the conference brought together leading European specialists – both from within the Joint Action and beyond the consortium – as well as participants from Taiwan, fostering international collaboration and the exchange of expertise.
Throughout the day, participants explored topics such as the ethical and social implications of personalised screening, risk-based screening models for cervical, breast, colorectal, prostate, lung, and gastric cancers. Sessions also highlighted emerging technologies, including liquid biopsies, polygenic risk scores (PRS), and the role of artificial intelligence in screening.
The final plenary session addressed the importance of effective communication and citizen engagement in implementing personalised cancer screening programmes across healthcare systems.
The conference marks an important step towards personalised cancer prevention, which will help improve early diagnosis, reduce unnecessary examinations, and promote more efficient use of healthcare resources across Europe.
#EuCanScreen #CancerScreening #HealthCare #CancerPrevention #Conference #PersonalisedCancerScreening
The general objective of EUCanScreen is to assure sustainable implementation of high-quality screening for breast, cervical and colorectal cancers, as well as implementation of the recently recommended screening programs – for lung, prostate and gastric cancers. EUCanScreen will facilitate the reduction of cancer burden and achieving equity across the EU.
This project has received funding from the European Union’s EU4HEALTH Programme under the Grant Agreement no 101162959